Prime Medicine
PRME
PRME
83 hedge funds and large institutions have $472M invested in Prime Medicine in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 35 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3.45% more ownership
Funds ownership: 47.45% → 50.89% (+3.4%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
30% less capital invested
Capital invested by funds: $676M → $472M (-$203M)
Holders
83
Holding in Top 10
2
Calls
$97K
Puts
$10K
Top Buyers
| 1 | +$10.3M | |
| 2 | +$5.89M | |
| 3 | +$5.45M | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
+$5.42M |
| 5 |
BlackRock
New York
|
+$4.25M |
Top Sellers
| 1 | -$5.82M | |
| 2 | -$4.23M | |
| 3 | -$3.76M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.53M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.11M |